Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 11, 2006, Pages 590-591

  Delbaere, Anne ^a,b   Smits, Guillaume ^e   Vassart, Gilbert ^c   Costagliola, Sabine ^d  

^a ERASME HOSPITAL   (Belgium)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d FNRS   (Belgium)

^e BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; COHORT ANALYSIS; DISEASE SEVERITY; FERTILIZATION IN VITRO; GENETIC SUSCEPTIBILITY; GRANULOSA CELL; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; NEGATIVE FEEDBACK; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROMOTER REGION; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY;

EID: 33750616215     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0319     Document Type: Short Survey

References (10)

1. Delvigne A and Rozenberg S (2002) Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8: 559-577
2. De Leener A et al. (2006) Presence and absence of FSH receptor mutations provide some insights to spontaneous ovarian hyperstimulation physiopathology. J Clin Endocrinol Metab 91: 555-562
3. Vasseur C et al. (2003) A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 349: 753-759
4. Smits G et al. (2003) Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 349: 760-766
5. Delbaere A et al. (2004) New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Hum Reprod 19: 486-489
6. Simoni M et al. (2002) Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 8: 413-421
7. Greb RR et al. (2005) A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 90: 4866-4872
8. Behre HM et al. (2005) Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 15: 451-456
9. Daelemans C et al. (2004) Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 89: 6310-6315
10. De Castro F et al. (2005) Pharmacogenetics of controlled ovarian hyperstimulation. Pharmacogenomics 6: 629-637